The role of selinexor in early rrMM and sequencing in 2024.

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/9a/f2/d4/9af2d436-04cf-a8a2-7fe6-ed50bdd0c74b/mza_1982894803558023697.jpg/600x600bb.jpg

Science For The Real World: Canadian Hematology Today

Catalytic Health

2 episodes

5 days ago

Science for the Real World is designed to illuminate hot topics in Canadian healthcare through a series of conversations with Canadian clinicians. Canadian Hematology Today presents robust clinical perspectives and practical insights on the treatment and management of hematologic diseases.

Medicine

Health & Fitness

RSS

All content for Science For The Real World: Canadian Hematology Today is the property of Catalytic Health and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/41510732/41510732-1719321990812-610ef6357faa9.jpg

The role of selinexor in early rrMM and sequencing in 2024.

Science For The Real World: Canadian Hematology Today

27 minutes 34 seconds

1 year ago

The role of selinexor in early rrMM and sequencing in 2024.

In this episode of "Science for the Real World: Canadian Hematology Today," Dr. Peter Anglin hosts a discussion with Dr. Joshua Richter and Dr. Darrell White on the management of early rrMM in 2024, focusing on the role of selinexor and treatment sequencing.